Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Nakajima

Showing results (51-60 of 288) with videos related to

Pageof 29
Sort By:
Biochemical Pharmacology|November 19, 2013
Epigenetic regulation of the tissue-specific expression of human UDP-glucuronosyltransferase (UGT) 1A10Shingo Oda, Tatsuki Fukami, Tsuyoshi Yokoi, et al.
Biochemical Pharmacology|September 18, 2021
m<sup>6</sup>A modification impacts hepatic drug and lipid metabolism properties by regulating carboxylesterase 2Seiya Takemoto, Masataka Nakano, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2013
Prilocaine- and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activationRyota Higuchi, Tatsuki Fukami, Miki Nakajima, et al.
The Journal of Biological Chemistry|February 13, 2008
Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4Shingo Takagi, Miki Nakajima, Takuya Mohri, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2008
Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT)1A9 and UGT1A8Ryoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Biochemical Pharmacology|September 1, 2009
Transcriptional regulation of human carboxylesterase 1A1 by nuclear factor-erythroid 2 related factor 2 (Nrf2)Taiga Maruichi, Tatsuki Fukami, Miki Nakajima, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 21, 2012
Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in ratsTheerada Taesotikul, Miki Nakajima, Wichittra Tassaneeyakul, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2016
Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and DogTakaya Kurokawa, Tatsuki Fukami, Tomohiro Yoshida, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 18, 2019
Identification of Novel Metabolites of Vildagliptin in Rats: Thiazoline-Containing Thiol Adducts Formed via Cysteine or Glutathione ConjugationKatsuhiko Mizuno, Kenji Takeuchi, Ken Umehara, et al.
Drug Metabolism and Pharmacokinetics|April 8, 2026
N<sup>6</sup>-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549 cellsTakuto Inamoto, Masataka Nakano, Tatsuki Fukami, et al.
Pageof 29

Showing results (51-60 of 288) with videos related to

Sort By:
Pageof 29
Biochemical Pharmacology|November 19, 2013
Epigenetic regulation of the tissue-specific expression of human UDP-glucuronosyltransferase (UGT) 1A10Shingo Oda, Tatsuki Fukami, Tsuyoshi Yokoi, et al.
Biochemical Pharmacology|September 18, 2021
m<sup>6</sup>A modification impacts hepatic drug and lipid metabolism properties by regulating carboxylesterase 2Seiya Takemoto, Masataka Nakano, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2013
Prilocaine- and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activationRyota Higuchi, Tatsuki Fukami, Miki Nakajima, et al.
The Journal of Biological Chemistry|February 13, 2008
Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4Shingo Takagi, Miki Nakajima, Takuya Mohri, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2008
Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT)1A9 and UGT1A8Ryoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Biochemical Pharmacology|September 1, 2009
Transcriptional regulation of human carboxylesterase 1A1 by nuclear factor-erythroid 2 related factor 2 (Nrf2)Taiga Maruichi, Tatsuki Fukami, Miki Nakajima, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 21, 2012
Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in ratsTheerada Taesotikul, Miki Nakajima, Wichittra Tassaneeyakul, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2016
Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and DogTakaya Kurokawa, Tatsuki Fukami, Tomohiro Yoshida, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 18, 2019
Identification of Novel Metabolites of Vildagliptin in Rats: Thiazoline-Containing Thiol Adducts Formed via Cysteine or Glutathione ConjugationKatsuhiko Mizuno, Kenji Takeuchi, Ken Umehara, et al.
Drug Metabolism and Pharmacokinetics|April 8, 2026
N<sup>6</sup>-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549 cellsTakuto Inamoto, Masataka Nakano, Tatsuki Fukami, et al.
Pageof 29